RIG
37
2
ED
55
3
HCP
70
4
EA
52
3
PRGO
39
2
EXC
54
3
CMG
50
-13
CME
50
-8
AVY
65
-3
CI
65
3
KLAC
63
-5
YUM
56
4
EIX
74
2
LEG
35
6
MTCH
55
5
IPG
42
2
LB
30
-4
ITW
67
3
AA
61
-2
ACN
52
-20
RIG
37
2
ED
55
3
HCP
70
4
EA
52
3
PRGO
39
2
EXC
54
3
CMG
50
-13
CME
50
-8
AVY
65
-3
CI
65
3
KLAC
63
-5
YUM
56
4
EIX
74
2
LEG
35
6
MTCH
55
5
IPG
42
2
LB
30
-4
ITW
67
3
AA
61
-2
ACN
52
-20
Financhill
Back

Kulicke & Soffa Industries Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
55

KLIC
Kulicke & Soffa Industries

Last Price:
44.76
Seasonality Move:
7.04%
Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
275.08
Seasonality Move:
4.48%
Buy
55
Kulicke & Soffa Industries (KLIC) is a Buy

Is Kulicke & Soffa Industries a Buy, Sell or Hold?

  • The current Kulicke & Soffa Industries [KLIC] share price is $44.77. The Score for KLIC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • KLIC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KLIC Stock Price Chart

What is Kulicke & Soffa Industries's stock price today?

  • The Kulicke & Soffa Industries share price today is $44.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KLIC is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $274.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

KLIC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 63.03 Buy
Chaikin Money Flow: -86565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.68 - 43.24) Buy
Bollinger Bands (100): (41.72 - 48.64) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.58 Buy
Relative Strength Index (14 RSI): 58.54 Buy
Chaikin Money Flow: 227264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.28 - 277.8) Buy
Bollinger Bands (100): (173.47 - 275.75) Buy

KLIC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.55 Buy
20-day SMA: 41.09 Buy
50-day SMA: 42.67 Buy
200-day SMA: 47.55 Sell
8-day EMA: 42.8 Buy
20-day EMA: 42 Buy
50-day EMA: 42.9 Buy
200-day EMA: 46.32 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 273.53 Buy
20-day SMA: 264.94 Buy
50-day SMA: 262.48 Buy
200-day SMA: 194.67 Buy
8-day EMA: 272.54 Buy
20-day EMA: 269.21 Buy
50-day EMA: 257.72 Buy
200-day EMA: 211.82 Buy

Kulicke & Soffa Industries Earnings Growth & KLIC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.22 per share, a decrease this year of $1.68 per share, and an increase next year of $1.93 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.

Kulicke & Soffa Industries Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):